A Japanese Bioventure Company's Application of Stem Cell Technology in Regenerative Medicine

Masanori Sawada, Daisuke Sugiyama, Takenobu Nii, Katsuhiro Konno, Hardy T.S. Kagimoto

研究成果: Contribution to journalArticle査読

4 被引用数 (Scopus)

抄録

Regenerative medicine mediated by the transplantation of somatic stem cells and functional cells derived from induced pluripotent stem cells has great potential in the treatment of currently incurable diseases and thus has attracted significant public attention. To put this into practice, several functional cell lines were developed and laws regarding regenerative medicine were put in force in Japan. In this report, we introduce recent efforts of a bioventure company with special attention to the case of Healios K.K.

本文言語英語
ページ(範囲)1801-1806
ページ数6
ジャーナルClinical Therapeutics
40
11
DOI
出版ステータス出版済み - 11 2018

All Science Journal Classification (ASJC) codes

  • 薬理学
  • 薬理学(医学)

フィンガープリント

「A Japanese Bioventure Company's Application of Stem Cell Technology in Regenerative Medicine」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル